Literature DB >> 36180714

Behavioral and Fluorescent-Based Immunohistochemistry Protocols for Examining Antidepressant-Like Effects of Melatonin in Mice.

Estrada-Reyes Rosa1, Muñoz Estrada Jesús2, Benítez-King Gloria3.   

Abstract

Antidepressants are characterized by their ability to decrease despair behavior assessed in mice as a decrease in immobility time in the forced swimming test (FST) (antidepressant-like behavior). This behavioral parameter is associated with increased neurogenesis in the dentate gyrus of the hippocampus of the rodents summitted to this test. Herein, we describe an optimized protocol used to characterize the melatonin antidepressant-like effect associated with its pro-neurogenic activity after an acute and a triple administration to mice measured by the FST and fluorescence-based immunohistochemistry in brain tissue, respectively.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Forced swimming test; Hippocampus; Immunohistochemistry; Melatonin; Neurogenesis

Mesh:

Substances:

Year:  2022        PMID: 36180714     DOI: 10.1007/978-1-0716-2593-4_45

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Melatonin synergizes with citalopram to induce antidepressant-like behavior and to promote hippocampal neurogenesis in adult mice.

Authors:  Gerardo Ramírez-Rodríguez; Nelly Maritza Vega-Rivera; Julián Oikawa-Sala; Ariadna Gómez-Sánchez; Leonardo Ortiz-López; Erika Estrada-Camarena
Journal:  J Pineal Res       Date:  2014-04-11       Impact factor: 13.007

3.  Central nervous system effects and chemical composition of two subspecies of Agastache mexicana; an ethnomedicine of Mexico.

Authors:  Rosa Estrada-Reyes; C López-Rubalcava; Octavio Alberto Ferreyra-Cruz; Ana María Dorantes-Barrón; G Heinze; Julia Moreno Aguilar; Mariano Martínez-Vázquez
Journal:  J Ethnopharmacol       Date:  2014-01-21       Impact factor: 4.360

4.  Role of the MT1 and MT2 melatonin receptors in mediating depressive- and anxiety-like behaviors in C3H/HeN mice.

Authors:  J Liu; S J Clough; M L Dubocovich
Journal:  Genes Brain Behav       Date:  2017-02-20       Impact factor: 3.449

5.  Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

Authors:  J E Malberg; A J Eisch; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

6.  Impact of COVID-19 on the mental health in a cohort of Italian rehabilitation healthcare workers.

Authors:  Giacomo Farì; Alessandro de Sire; Vincenzo Giorgio; Laura Rizzo; Antonella Bruni; Francesco P Bianchi; Alessandra Zonno; Paola Pierucci; Maurizio Ranieri; Marisa Megna
Journal:  J Med Virol       Date:  2021-08-23       Impact factor: 20.693

7.  Behavioral despair in mice: a primary screening test for antidepressants.

Authors:  R D Porsolt; A Bertin; M Jalfre
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-10

8.  A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.

Authors:  Carlos A Zarate; Daniel Mathews; Lobna Ibrahim; Jose Franco Chaves; Craig Marquardt; Immaculata Ukoh; Libby Jolkovsky; Nancy E Brutsche; Mark A Smith; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

9.  Melatonin modulates cell survival of new neurons in the hippocampus of adult mice.

Authors:  Gerardo Ramírez-Rodríguez; Friederike Klempin; Harish Babu; Gloria Benítez-King; Gerd Kempermann
Journal:  Neuropsychopharmacology       Date:  2009-05-06       Impact factor: 7.853

10.  Antidepressant-like effects of melatonin in the mouse chronic mild stress model.

Authors:  Bernardo C Detanico; Angelo L Piato; Jennifer J Freitas; Francisco L Lhullier; Maria P Hidalgo; Wolney Caumo; Elaine Elisabetsky
Journal:  Eur J Pharmacol       Date:  2009-02-26       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.